MRVL has gained 7% on the week and now trades at $176.27 — with analysts racing to close a target gap that has narrowed sharply but not yet closed.
The standout development this week is the acceleration in analyst target upgrades, with multiple firms lifting numbers in the two trading days alone. Oppenheimer's Rick Schafer raised his target to $200 from $170 on May 20, maintaining Outperform. Wells Fargo's Aaron Rakers went further, lifting to $195 from $135 the same morning. Evercore ISI moved to $155 from $133 on May 19. TD Cowen — holding a lone Hold — raised to $190 from $90, an unusually large move for a cautious rating. RBC Capital lifted to $200 from $170 on May 14. The direction of travel is unambiguous: the Street is chasing the stock higher. A previously published note flagged that the consensus mean target of $120.88 looked badly stale, and that view has now been validated — with the stock at $176.27 and multiple fresh targets clustered in the $190–$200 range, the lagged consensus figure should be treated as an artifact of the old setup rather than a live valuation signal.
The bull case centres on data centre momentum. Marvell's interconnect business guides to better than 50% year-over-year growth in FY27. The data centre segment delivered roughly 9% sequential growth in the last print, and communications end markets are recovering. Bears point to two specific risks: hyperscaler capex could soften, which would hit Marvell harder than most given its customer concentration; and gross margins are guiding slightly lower sequentially. TD Cowen's Hold at $190 — above the current price — captures the tension neatly: the growth story is credible, but valuation has moved fast. The PE has expanded roughly 5.5 points over the past 30 days to 39.8x, and EV/EBITDA has risen about 1 point on the week to 33.1x. Quality and financial health remain standout characteristics — the ORTEX stock score flags a near-perfect F-score and a Z-score well above distress thresholds — but the value factor score at 33 out of 100 confirms the stock is no longer cheap by conventional measures.
Positioning in the lending market is entirely relaxed. Short interest is modest at 3.6% of free float, up about 14% over the past month but from a low base and with no sign of urgency — the short score has barely budged, sitting at 32 all week. Borrow availability is extraordinarily loose, running above 8,000% of current short interest, meaning the lending pool is almost entirely unused. Cost to borrow has eased nearly 19% over the past month to 0.25%. None of this points to meaningful short-side pressure. Options positioning is slightly more guarded: the put/call ratio has nudged up to 1.29, modestly above its 20-day average of 1.26, though the z-score of 0.9 makes this a mild lean rather than a firm defensive signal. Taken together, positioning looks comfortable rather than charged — the marginal caution is in options, not in shorting.
Insiders are selling into strength. CEO Matt Murphy sold $1.3m worth of shares on May 13 at $177.26. COO Chris Koopmans received a stock award on May 15 and sold $4.9m on the same day at $176.89. CFO Willem Meintjes sold $700k on May 15 at $175.24. Net insider activity over 90 days shows a positive nominal figure driven by awards, but the open-market sales have been consistent as the stock has rallied — a pattern typical of executives monetising equity compensation rather than expressing a directional view, though the volume has picked up alongside the price appreciation.
The last earnings print provides useful context. MRVL moved +14.7% on the day of the March 5 release and gained a further 12.3% over the following five days — one of the largest post-earnings rallies in recent memory for the stock. The May 27 print arrives with the stock up 26% over the past month and analysts having already moved their targets higher. Whether the setup supports another outsized reaction — or whether the good news is already in the price — is precisely the question the May 27 call will answer.
See the live data behind this article on ORTEX.
Open MRVL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
